Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Synthetic or structurally-modified peptidoglycan or...
Patent
1975-05-12
1976-06-22
Moyer, Donald B.
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
Synthetic or structurally-modified peptidoglycan or...
A61K 31365
Patent
active
039652750
ABSTRACT:
A process, and the composition used therein, for estrogenic therapy which comprises administering daily to the patient from about 0.2 to 2000 milligrams of a compound having the formula: ##EQU1## wherein R is selected from the group consisting of hydrogen, lower alkyl and a lower saturated acyclic acyl; Z is selected from the group consisting of >CH.sub.2, >CHOH and >C=O; and A is selected from the group consisting of --CH.sub.2 --CH.sub.2 -- and --CH=CH--.
REFERENCES:
patent: 3239341 (1966-03-01), Hodge et al.
patent: 3239342 (1966-03-01), Hodge et al.
patent: 3239345 (1966-03-01), Hodge et al.
patent: 3239347 (1966-03-01), Hodge et al.
Goodman et al., The Pharmaceutical Basis of Therapeutics, 3rd Ed., pp. 1382, 1383, 1541-1544, 1548-1552, The MacMillan Co. N.Y. (1965).
Chemical Abstracts vol. 72: 53749u; vol. 72: 41764g; vol. 69: 1932s; vol. 69: items 1933t, 42911c, 42912d, 86648b, 86649c, 86650w, 86651x, 86652y, 86653z, 86654a, 86655b, 96505s and 106281g.
Baldwin Robert S.
Hidy Phil H.
Commercial Solvents Corporation
Moyer Donald B.
LandOfFree
Composition and method does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2288921